ES2002430A6 - Procedimiento para preparar alcanamidas, carbamatos y ureas. - Google Patents

Procedimiento para preparar alcanamidas, carbamatos y ureas.

Info

Publication number
ES2002430A6
ES2002430A6 ES8602834A ES8602834A ES2002430A6 ES 2002430 A6 ES2002430 A6 ES 2002430A6 ES 8602834 A ES8602834 A ES 8602834A ES 8602834 A ES8602834 A ES 8602834A ES 2002430 A6 ES2002430 A6 ES 2002430A6
Authority
ES
Spain
Prior art keywords
pyridazin
triazolo
ureas
carbamates
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8602834A
Other languages
English (en)
Inventor
Jay Donald Albright
Dennis William Powell
John Paul Dusza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES2002430A6 publication Critical patent/ES2002430A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR ALCANAMIDAS, CARBAMATOS Y UREAS, DE FORMULA (I), DONDE R1 ES HIDROGENO O ALQUILO (C1-C3); R2 SE ELIGE DEL GRUPO CONSISTENTE EN HIDROGENO, ALQUILO (C1-C6), CICLOALQUILO (C3-C6), -O-ALQUILO (C1-C6), -NH-ALQUILO (C1-C6), -N-DIALQUILO (C1-C3), -CH2)N-O-ALQUILO (C1-C3), -(CH2)N-NH-ALQUILO (C1-C3) Y -(CH2)N-N-DIALQUILO (C1-C3), EN DONDE N ES UN ENTERO DE 1 A 3 INCLUSIVE; Y R3 SE ELIGE DEL GRUPO CONSISTENTE EN ALQUILO (C1-C6), ALQUENILO (C2-C6), -CH2-CFCH, CICLOALQUIL (C3-C6)METILO, -CH2OCH3 Y -CH2CH2OCH3. SE OBTIENEN POR REACCION DE 3-CLORO-6-(3-NITROFENIL)PIRIDAZINA CON UNA FORMIL-HIDRAZIDA O ALCANOIL-HIDRADINA, REDUCCION DEL COMPUESTO RESULTANTE DE FORMULA (III) Y REACCION DEL COMPUESTO RESULTANTE CON UN COMPUESTO DE FORMULA R2COCL O (R2CO)2O. SON UTILES COMO AGENTES ANSIOLITICOS O ANTIEPILEPTICOS.
ES8602834A 1985-10-31 1986-10-30 Procedimiento para preparar alcanamidas, carbamatos y ureas. Expired ES2002430A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/793,437 US4654343A (en) 1985-10-31 1985-10-31 N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas

Publications (1)

Publication Number Publication Date
ES2002430A6 true ES2002430A6 (es) 1988-08-01

Family

ID=25159919

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8602834A Expired ES2002430A6 (es) 1985-10-31 1986-10-30 Procedimiento para preparar alcanamidas, carbamatos y ureas.

Country Status (12)

Country Link
US (1) US4654343A (es)
EP (1) EP0223974A1 (es)
JP (1) JPS62108882A (es)
KR (1) KR900004833B1 (es)
AU (1) AU591940B2 (es)
DK (1) DK519486A (es)
ES (1) ES2002430A6 (es)
FI (1) FI864423A (es)
HU (1) HU196209B (es)
NO (1) NO165194C (es)
NZ (1) NZ218063A (es)
ZA (1) ZA868280B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892873A (en) * 1985-10-31 1990-01-09 American Cyanamid Company N-substituted -N-(3-(1,2,4-triazolo-(4,3-b)pyridazin-6-yl)phenyl)alkanamides, carbamates and ureas
GB9507348D0 (en) * 1995-04-08 1995-05-31 Knoll Ag Therapeutic agents
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
US6297235B1 (en) * 1997-08-28 2001-10-02 Merck Sharp & Dohme Ltd. Triazolopyridazine derivatives for treating anxiety and enhancing cognition
GB9718254D0 (en) * 1997-08-28 1997-11-05 Merck Sharp & Dohme Therapeutic agents
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9723999D0 (en) 1997-11-13 1998-01-14 Merck Sharp & Dohme Therapeutic use
GB9726702D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9726699D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
US6110915A (en) * 1997-12-18 2000-08-29 Merck & Co., Inc. Antiemetic use of triazolo-pyridazine derivatives
JP2002509150A (ja) 1998-01-14 2002-03-26 メルク シャープ エンド ドーム リミテッド Ｇａｂａ受容体のリガンドとしてのトリアゾロピリダジン誘導体
GB9801234D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
NZ504870A (en) * 1998-01-21 2002-11-26 Merck Sharp & Dohme Triazolo-pyridazine derivatives as ligands for gaba receptors
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801210D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) * 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
TWI334868B (en) 2003-06-03 2010-12-21 Nippon Kayaku Kk [1,2,4] triazoro [1,5-a] pyrimidine-2-ylurea derivative and use thereof
KR100658771B1 (ko) * 2004-05-31 2006-12-15 고려대학교 산학협력단 고추 유래의 ＣａＯＤＣ1 유전자 도입 재조합 벡터 및이를 이용하여 형질전환된 식물병 저항성 향상 담배 변종식물체
WO2006050389A2 (en) 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds, compositions and methods
WO2006050359A2 (en) * 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds and methods
TW200719895A (en) * 2005-05-26 2007-06-01 Wyeth Corp Method for the treatment of noise phobia in companion animals
WO2007127375A2 (en) * 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
EP2015751A2 (en) * 2006-04-28 2009-01-21 Northwestern University Salts of pyridazine compounds
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
EP2131839A2 (en) * 2007-03-02 2009-12-16 Northwestern University Compositions comprising derivatives of 3-phenylpyridazine for treating seizure-related disorders
US8188083B2 (en) * 2007-06-28 2012-05-29 Abbott Laboratories Triazolopyridazines
DK2464645T3 (en) 2009-07-27 2017-10-23 Gilead Sciences Inc CONDENSED, HETEROCYCLIC COMPOUNDS AS IRON CHANNEL MODULATORS
CN103096977B (zh) 2010-07-02 2017-02-15 吉利德科学公司 作为离子通道调节剂的稠杂环化合物
WO2012154760A1 (en) 2011-05-10 2012-11-15 Gilead Sciences, Inc. Fused heterocyclic compounds as sodium channel modulators
NO3175985T3 (es) 2011-07-01 2018-04-28
TWI549944B (zh) 2011-07-01 2016-09-21 吉李德科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
CN112225741B (zh) * 2020-12-09 2021-03-30 中山大学 1,2,4三唑并4,3-b哒嗪衍生物在制备抗炎症因子风暴药物中的应用
WO2024074483A1 (en) * 2022-10-04 2024-04-11 Eth Zurich Compounds for the treatment of myotonic dystrophy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230705A (en) * 1976-09-22 1980-10-28 American Cyanamid Company 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
CA1080712A (en) * 1976-09-22 1980-07-01 Jay D. Albright Hypotensive agents
US4112095A (en) * 1976-10-07 1978-09-05 American Cyanamid Company 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents
PH12424A (en) * 1976-10-26 1979-02-15 American Cyanamid Co Method of treating anxiety in mammals
US4260755A (en) * 1979-10-31 1981-04-07 American Cyanamid Company Novel 6-phenyl and substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines
DE3217325A1 (de) * 1982-05-08 1983-11-10 Hoechst Ag, 6230 Frankfurt 3-amino-6-aryl-1,2,4-triazolo(4,3-b)-pyridazine, ihre herstellung und ihre verwendung
DE3311753A1 (de) * 1983-03-31 1984-10-04 Hoechst Ag, 6230 Frankfurt Substituierte 6-aryl-1,2,4-triazolo(4,3-b)pyridazine - ihre herstellung und verwendung -

Also Published As

Publication number Publication date
NO864336D0 (no) 1986-10-30
KR900004833B1 (ko) 1990-07-07
US4654343A (en) 1987-03-31
NO864336L (no) 1987-05-04
FI864423A (fi) 1987-05-01
HU196209B (en) 1988-10-28
KR870004034A (ko) 1987-05-07
NZ218063A (en) 1990-03-27
DK519486A (da) 1987-05-01
NO165194C (no) 1991-01-09
JPS62108882A (ja) 1987-05-20
EP0223974A1 (en) 1987-06-03
AU6454986A (en) 1987-05-07
HUT43609A (en) 1987-11-30
NO165194B (no) 1990-10-01
FI864423A0 (fi) 1986-10-30
DK519486D0 (da) 1986-10-30
AU591940B2 (en) 1989-12-21
ZA868280B (en) 1987-06-24

Similar Documents

Publication Publication Date Title
ES2002430A6 (es) Procedimiento para preparar alcanamidas, carbamatos y ureas.
CS546986A1 (en) N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
PT82127A (en) Process for the preparation of phenyl carbamates
AU569086B2 (en) 2-pyrimidinyl-1-piperazine derivatives
TR200000197T2 (tr) Yeni bileşimler
HUT45021A (en) Process for production of insecticides and acaricides containing pirasoline-derivatives as active substance and process for production of the active substances
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
HK15292A (en) (3-amino-1h-pyrazol-4-yl)(aryl)methanones
IL72208A (en) Aryl and heteroaryl(7-(aryl and heteroaryl)pyrazolo-(1,5-a)pyrimidin-3-yl)methanones,their preparation and pharmaceutical compositions containing them
DK454685D0 (da) Pyrazolo(3,4-b)-pyridinamider
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
EP0333000A3 (en) Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
ES8700650A1 (es) Procedimiento para preparar derivados de acidos 7-(ariloxi)-2-naftiloxi-alcancarboxilicos racemicos e isomeros
FI875501A (fi) 6,7-dihydro-/1,2,4/triazolo/1,5-a// 1,3,5/triazin-2-sulfonsyraamider, foerfarande foer deras framstaellning och deras anvaendning som medel med herbicid och vaextreglerande verkan.
ES476837A1 (es) Procedimientos de preparar derivados pirimidinicos condensa-dos con cabeza de puente de nitrogeno.
JPS53103441A (en) Preparation of optical active phenylglycines
ZA86937B (en) Acyl ureas,insecticidal compositions containing these compounds as well as processes for their preparation
PT73948A (en) Process for the preparation of biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
SU879946A1 (ru) 2,3-диметил-8-(n-бромфенил)имидазо[4,5-g] индолизин, обладающий акарицидной активностью